Dr. Rafat Abonour is a physician-scientist dedicated to improving outcomes for patients with multiple myeloma and related plasma cell disorders. Over the past three decades, He has built comprehensive clinical and research programs that integrate cutting-edge therapies, clinical trials, and precision health approaches. His work bridges translational research and real-world data to better understand disease biology and guide personalized treatment strategies.
He established one of the nation’s largest myeloma registries, linking clinical and biological data to accelerate discovery and innovation. This initiative has supported numerous NIH- and industry-funded studies and fostered collaboration across disciplines and institutions. Throughout his career, He has been committed to mentoring young investigators and expanding access to advanced care for patients everywhere.
